Loss of response to anti-TNFalpha agents depends on treatment duration in patients with inflammatory bowel disease. Schultheiss JPD, Mahmoud R, Louwers JM, van der Kaaij MT, et al. Aliment Pharmacol Ther 2021 Sep 24. doi: 10.1111/apt.16605.

Read + Share

Amedeo Smart

Independent Medical Education

Schultheiss JPD, Mahmoud R, Louwers JM, van der Kaaij MT, et al. Loss of response to anti-TNFalpha agents depends on treatment duration in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2021 Sep 24. doi: 10.1111/apt.16605.
PMID: 34559428